DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main

Bank

Position in BHC — Bausch Health Companies Inc.

CIK 1694217 FRANKFURT AM MAIN, 2M

Back to BHC Full portfolio

Position in BHC

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$7,366,430

+$1,352,153 QoQ

Shares Held

1,494,205

+34.2% QoQ

Ownership

0.400%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#25

of 220 holders

Holding Since

Dec 2021

6 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Common Shares in BHC Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main holds $85,155,241 across 11 Drug Manufacturers - Specialty & Generic names. BHC ranks #3 (8.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TEVA	Teva Pharmaceutical Industries Ltd	1,400,743	$47,457,172
2	NBIX	Neurocrine Biosciences Inc	112,059	$18,886,423
3	BHC	Bausch Health Companies Inc. This page	1,494,205	$7,366,430
4	RDY	Dr Reddys Laboratories Ltd	409,000	$5,926,410
5	ZTS	Zoetis Inc.	38,000	$2,730,679
6	SUPN	Supernus Pharmaceuticals, Inc.	39,690	$1,845,981
7	UTHR	UNITED THERAPEUTICS Corp	966	$523,407
8	VTRS	Viatris Inc	23,124	$367,208

All Filings in BHC

Export CSV

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,366,430	1,494,205	+34.2%	Shares	Defined	2026-08-14
2026-03-31	$6,014,277	1,113,755	+42.0%	Shares	Defined	2026-05-15
2025-12-31	$5,452,434	784,523	+47.2%	Shares	Defined	2026-02-17
2025-09-30	$3,437,340	532,921	+2260.6%	Shares	Defined	2025-11-14
2022-03-31	$515,861	22,576	0.0%	Shares	Defined	2026-05-04
2021-12-31	$623,323	22,576	—	Shares	Defined	2026-05-04
No filing history on record for this holder in this stock.